Poorva Bindal to Rituximab
This is a "connection" page, showing publications Poorva Bindal has written about Rituximab.
Connection Strength
0.804
-
Bindal P, Jalil SA, Holle LM, Clement JM. Potential role of rituximab in metastatic castrate-resistant prostate cancer. J Oncol Pharm Pract. 2019 Sep; 25(6):1509-1511.
Score: 0.590
-
Arun Kumar S, Mishra R, Malempati SC, Bindal P. Primary cardiac large B cell lymphoma. BMJ Case Rep. 2023 Dec 26; 16(12).
Score: 0.214